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West Nile virus (WNV) is a zoonotic arboviral pathogen transmitted by mosquitoes in a cycle involving wild birds as
reservoir hosts. The virus has recently emerged in North America and re-emerged in Europe. North American WNV
outbreaks are often accompanied by high mortality in wild birds, a feature that is uncommon in Europe. The reason
for this difference is unknown, but the intrinsic virulence of the viruses circulating in each continent and/or the
susceptibility to the disease of Palearctic as opposed to Nearctic wild bird species could play a role. To assess this
question, experimental inoculations with four lineage 1 WNV strains, three from southern Europe (Italy/2008, Italy/
2009 and Spain/2007) and one from North America (NY99) were performed on house sparrows (Passer domesticus),
a wild passerine common in both continents. Non-significant differences which ranged from 0% to 25% were
observed in mortality for the different WNV strains. Viremias lasted from 1 to 5–6 days post-inoculation (dpi) in
all cases; individuals inoculated with NY99 had significantly higher titres than those inoculated with any of the
Euro-Mediterranean strains. Remarkably, host competence was found to be higher for NY99 than for the other
strains. Consequently, albeit being pathogenic for house sparrows, some Euro-Mediterranean strains had reduced
capacity for replication in -and transmission from- this host, as compared to the NY99 strain. If applicable also to
other wild bird host species, this relatively reduced transmission capacity of the Euro-Mediterranean strains could
explain the lower incidence of this disease in wild birds in the Euro-Mediterranean area.Introduction
West Nile virus (WNV, Flaviviridae family, Flavivirus
genus) is an arthropod-borne pathogen of humans, horses
and some birds [1]. In recent years WNV has expanded its
geographical range dramatically and is now considered to
be one of the most widespread arboviruses in the world
[2-4]. In North America, since its introduction in 1999,
WNV has provoked thousands of cases in humans and
animals, and has caused extensive mortality in wild
birds [5]. By contrast, in Europe, where the disease is
re-emerging, WNV only causes sporadic clinical cases
and self-limited outbreaks, with no (or only very limited)
wild bird mortality [4,5]. The reason for these observed
differences in wild bird mortality is unknown but could be* Correspondence: majimenez@inia.es
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unless otherwise stated.related either to the relative intrinsic virulence of the
WNV strains circulating in each continent and/or to a
different susceptibility to WNV infection in Palearctic
as opposed to Nearctic wild bird species, given that the
former have co-evolved with this pathogen while the
latter are naïve in this regard.
A useful approach for investigating this issue is the
performance of experimental infections in avian hosts
with strains of different origins [6]. The virulence of the
North American WNV prototype strain (NY99) in differ-
ent avian species has been assessed experimentally in a
number of studies [7-13] from which it is apparent that
this strain is highly pathogenic for certain species of birds,
notably – but not exclusively – Nearctic corvids [7]. The
house sparrow (Passer domesticus) (HoSp hereafter), an
abundant and ubiquitous passerine, has also been shown
to be susceptible to WNV disease after experimental
inoculation with the NY99 strain, with mortality ratesal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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bird species, HoSp could potentially represent a useful
model for experimental studies on the comparative viru-
lence of WNV strains with different geographical and/
or phylogenetic origins. A recent study compared the
virulence of NY99 in this host species with two other
WNV strains, namely KN-3829 and Kunjin-6453 [16].
The former was isolated in Kenya in 1998 and belongs
to the Western-Mediterranean-Eastern-European-Kenyan
phylogenetic cluster within lineage 1a [17], while the latter
was isolated in Australia in 1991 and belongs to lineage
1b. In the aforementioned study NY99 and KN-3829
induced similar mortalities, while Kunjin-6453 showed
no virulence in host birds. The fact that an Old World
WNV strain is as virulent as the North American
prototype strain for HoSp is intriguing since it implies
that the perceived mortalities in HoSp should also have
occurred in the Old World WNV outbreaks when, in
fact, no such observations have been reported.
Phylogenetically, KN-3829 is closely related to the
majority of WNV isolates that have been circulating
since 1996 in the western Mediterranean and Eastern
Europe; nevertheless, despite this, 6–13 amino-acid
residue substitutions still remain in the whole polypro-
tein sequence (3433 residues) between the Kenyan and
the Euro-Mediterranean strains. Small changes in the
viral RNA sequence may lead to relevant virulence
shifts [18,19] and so it is possible that the observed
virulence of the Kenyan strain for HoSp might not be
applicable to other WNV strains belonging to the same
phylogenetic cluster. In order to assess the virulence
for HoSp of other WNV strains belonging to the Euro-
Mediterranean cluster, wild HoSp captured in Spain
were inoculated with three Euro-Mediterranean lineage 1
WNV strains, Spain/2007, Italy/2008 and Italy/2009, and
the course of the infection was compared with that caused
by inoculation with the NY99 strain.
Materials and methods
Viruses and virus preparations
The four West Nile virus strains used in this work were
as follows: NY99-crow-V76/1, a North American WNV
strain, isolated from a diseased crow during the WNV
outbreak in New York in 1999 (GenBank accession n°
FJ151394); GE-1b/B, isolated from a golden eagle that
died as a consequence of WNV infection in Toledo, Spain
in 2007, (GenBank accession n° FJ766331 [20]; here-
after “Spain/2007”); Italy 15803/08, isolated from a magpie
hunted during a pest-control programme in Ravenna, Italy
in 2008 (GenBank accession n°: FJ483549; hereafter “Italy/
2008”); and Italy/2009, isolated from a yellow-legged
gull found moribund in Ravenna, Italy, in 2009, along
with several other WNV-infected individuals of the same
species, that died afterwards in a wildlife rehabilitationcentre (GenBank accession n°: JF719067). The NY99 strain
was obtained through the National Veterinary Service
Laboratories, USDA, lot n° 034EDV0601, while the other
WNV strains were those used in our previous works
[17,20,21]. All the above viruses were propagated and
titrated by plaque assays in Vero cells (ATCC CCL-81) and
were completely sequenced prior to inoculation in order
to ascertain that the viruses inoculated had nucleotide
sequences identical to those available in GenBank.
Birds and animal care
Free-living HoSp were captured using mist nets and
banded in the province of Sevilla, Spain. After habituation
in captivity for two months in Sevilla, they were trans-
ported to the high-level biocontainment facility at CISA
(Valdeolmos, Spain), where they were bled to determine
their pre-existing immunity to WNV and housed in indi-
vidual cages installed in the BSL-3 facilities. HoSp were
randomly distributed in groups of 8 individuals, composed
(whenever possible) of 50% males and 50% females. Mixed
bird-seed and water were supplied ad libitum. All the
animal care, handling and experimental procedures per-
formed in this work were supervised and approved by
the National Committee for Ethics and Welfare in Animal
Experimentation in Spain according to European legisla-
tion (Council Directive 86/609/EEC).
Experimental inoculations
After seven days of acclimatization in the BSL-3 room,
groups of 8 HoSp were inoculated subcutaneously in
the neck with 0.1 mL of viral suspension. Viruses were
previously diluted in DMEM supplemented with antibiotics
and glutamine, to obtain approximately 10.000 plaque-
forming units (pfu)/bird of the assigned WNV strain. Each
group was inoculated with a different WNV strain (see
“Viruses and virus preparations” section). At the same
time, a control group (n = 8), kept in separate cages in the
same room as the infected ones, was sham-inoculated
with an equivalent volume of diluent and manipulated in
the same way as the virus-inoculated groups.
Clinical follow-up and collection of samples
The experimental procedure was based on Sotelo et al.
[22], albeit with some modifications. All birds were
monitored daily for clinical signs of illness. To follow
the course of the viremia and viral load, 0.1 mL blood
samples (obtained from the jugular vein) were collected
at 1, 3, 5 and 7 days post-inoculation (dpi) from half of
the birds (four in each group) and at 2, 4, 6 and 8 dpi
from the other half, that is, from alternating individuals
in order to minimize animal manipulation, reduce un-
necessary stress and limit the risk of provoking anaemia
due to repeated bleeding. Similarly, oropharyngeal and
cloacal swab samples were collected from all birds one
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the birds, and at 2, 4, 8 and 12 dpi from the other half.
Blood samples were collected in sterile polypropylene
tubes filled with 0.9 mL BA-1 diluent (Hanks M-199
salts, 0.05 M Tris, pH 7.6, 1% bovine serum albumin,
0.35 g/L of sodium bicarbonate, 100 units/mL of penicillin,
100 μg/mL of streptomycin, 1 μg/mL of amphotericin B),
mixed and stored at −70 °C until analysis. Swab samples
were placed in sterile polypropylene tubes containing
1 mL PBS and immediately stored at −70 °C until analysis.
Birds that succumbed to the infection were necropsied
within 18 h following death. Single-use scalpels and
forceps were employed during necropsy to avoid the
cross-contamination of tissues. Tissue samples from the
brain, kidney, heart, liver and spleen were obtained from
birds succumbing to the infection, or euthanized at the
end of the experiment (21 dpi). One aliquot of sample was
homogenized in 0.9 mL PBS as described [22], while a
second was fixed with 4% buffered formaldehyde solu-
tion and processed for immunohistochemical analysis as
described [23] with the only exception that the primary
antibody was from a different source (P. Emrich, Bernhard
Nocht Institute, Germany). In order to obtain serum
for antibody detection techniques (see below), additional
blood samples (0.1–0.2 mL/individual) were taken prior to
inoculation and at 14 dpi. They were collected in dry tubes
and allowed to clot at 37 °C for 1 h, followed by incuba-
tion at 4 °C overnight.
Viremia and viral load assays
Viremia was measured using a standard plaque-formation
assay in Vero cells as previously described [24]. The viral
load in blood and tissue samples was measured essentially
as previously described [22] using a semi-quantitative
real-time RT-PCR method for the detection of the
lineage 1 WNV genome [25]. Virus shedding was assessed
in oropharyngeal and cloacal swabs using the same pro-
cedures. A Ct = 40.0 was set as cut-off for the real-time
RT-PCR used.
Antibody detection assays
Serum antibodies to WNV were detected by a commer-
cially available epitope-blocking ELISA (Ingezym West
Nile Compac, INGENASA, Madrid, Spain) suitable for
the detection of antibodies to WNV in the serum of wild
birds [26].
Calculation of host competence index (Ci) values
The calculation of competence index values for inoculated
HoSp was based on the formula described elsewhere
[27], considering infectious viremia values as all those
above > 105.0 pfu/mL for Culex pipiens mosquitoes as
has been previously described [28].Statistical analysis
The viremia and blood genome load of the different
inoculated groups were compared using a mixed-effects
ANOVA. Individual identity was included as a random
factor, while day, virus strain and the interaction between
day and virus strains were included as independent
factors.
Results
Pathogenicity and clinical signs
Table 1 provides a comparison of the deduced amino-acid
sequence from each of the four WNV strains used in this
work and highlights where amino-acid substitutions were
found in the sequences. In the group inoculated with the
NY99 strain two individuals succumbed to the infection
at 4 dpi. Euro-Mediterranean strains caused either the
same (Spain/2007 strain: 2/8), lower (Italy/2009: 1/8) or
no mortality (Italy/2008: 0/8) (Figure 1). The deaths caused
by the Euro-Mediterranean strains occurred 2–3 days (at
6–7 dpi) later than those caused by NY99 (4 dpi) (Figure 1).
In addition, two sparrows in the NY99-inoculated group
showed clinical signs, beginning at 4 dpi, that were
characterized by abnormal posture, apathy, prostration,
unresponsiveness and behavioural changes such as no
avoidance of capture. These signs remained until the end
of the monitoring period (14 dpi). No clinical signs were
observed in any of the HoSp surviving the inoculation
of the Euro-Mediterranean strains. All control sparrows
survived and none were infected (not shown).
Viremia and host competence analysis
All inoculated HoSp (except one, inoculated with Italy/
2008 strain, which remained negative throughout the
whole experiment) developed detectable viremias that
lasted up to 5–6 dpi (Figure 2). The NY99-inoculated
group showed a significantly higher mean peak viremia
(p < 0.05) than those HoSp inoculated with the Euro-
Mediterranean strains. Viral genome load data essen-
tially corroborated the results from the viremia analyses
(Figure 2). Viremias tended to be higher in the HoSp
succumbing to the infection than in the survivors. This
was particularly true for the two HoSp succumbing to
NY99 inoculation, which reached 9.0 and 9.1 log10 pfu
per mL of plasma respectively, while those surviving
NY99 infection developed a mean peak viremia of 6.9
log10 pfu per mL of plasma (n = 6).
Based on viremia levels, it is possible to estimate the
reservoir competence of a species with regards to a given
viral strain [7]. A threshold of 5 log10 pfu/mL of blood has
been calculated as the minimum amount of WNV needed
to infect Culex pipiens mosquitoes [28]. On average, all
groups of HoSp inoculated with the different WNV strains
exceeded this threshold, which indicates that the HoSp is
a competent host for the transmission of all the strains
Table 1 Amino-acid composition of the four tested WNV strains
Viral protein Amino-acid position Consensus NY99 Spain/2007 Italy/2009 Italy/2008
C 34 M - V - -
E
51 A - T - -
88 P - S - -
126 T I - - -
159 I V - - -
NS1
35 Y - H - -
70 S A - - -
208 D - H - -
284 T - - M -
289 E - G - -
NS2A
85 I - - V V
105 I - - - T
NS2B 103 A V - - -
NS3
249 P - - T -
356 I T - - -
NS4A
85 I A V - -
100 P - - S S
NS4B
115 A - T - -
249 D E - - -
NS5
53 H - - - Y
258 V - - A A
422 R - - K K
426 E - A - -
436 M - I - -
The amino-acid sequence of the four WNV strains is compared with the WNV consensus sequence. From the left, the first and second columns display viral protein
and amino-acid position, respectively, followed by the column displaying the consensus sequence and those corresponding to each WNV strain. The amino-acid
residue occupying each position is indicated with the single letter amino-acid code.
Figure 1 Survival of house sparrows infected with different WNV strains. NY99 (open squares), Spain/2007 (closed circles), Italy/2009 (open
triangles) and Italy/2008 (open circles). The percentage of house sparrows surviving in each group is plotted against days post-inoculation. No
mortality was found in the control group.
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Figure 2 Mean daily blood viral genome load (a) and viremia titres (b) plotted for four groups of eight house sparrows inoculated
with different WNV strains. NY99 (open squares), Spain/2007 (closed circles), Italy/2009 (open triangles) and Italy/2008 (open circles). Birds were
sampled every other day as described in the text. Error bars represent the standard error of the mean.
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in this respect in the competence indexes calculated for
each strain (Table 2). In particular, the HoSp is a better
competent host for the transmission of NY99 (Ci = 1.15)
than for the Euro-Mediterranean strains that were exam-
ined (Ci = 0.17-0.47).
Virus distribution in organs
In all inoculated HoSp developing viremia, the infection
was systemic as the virus was found in a wide range of
organs upon necropsy. In general, viral loads were the
highest in the spleen and then in the kidney. Liver had
intermediate viral loads, while the heart and brain, the
lowest values (Figure 3). Interestingly, certain differences
were observed between WNV strains: in all cases HoSp
inoculated with NY99 developed higher viral load in or-
gans than those inoculated with the Euro-Mediterranean
strains (Figure 3) in both dead and surviving birds (Table 3).
The observed viral loads in organs from the HoSp suc-
cumbing to the infection were remarkably higher than in
the organs from the surviving birds (Table 3); nevertheless,
these comparisons could be misleading since survivorsTable 2 Host competence index calculated for each group
of house sparrows
Strain Susceptibility (s) Infectiousness (i) Meanduration (d) Ci
NY99 1.00 0.37 3.11 1.15
Spain/2007 1.00 0.19 2.49 0.47
Italy/2009 1.00 0.15 1.43 0.21
Italy/2008 0.88 0.09 2.09 0.17
The competence index (Ci) reflects the relative number of infectious
mosquitoes that could be derived from feeding on a particular bird species (in
this case, house sparrows) infected by a given virus strain (in this case, four
WNV strains: NY99, Spain/2007; Italy/2008 and Italy/2009). Ci is determined as
the product of susceptibility (proportion of exposed birds that become
infected), infectiousness (proportion of vectors that become infected per day)
and transmissible viremia duration (number of days a bird maintains an
infectious viremia).must have cleared most of the virus by the time they
were necropsied at the end of the experiment (14 dpi).
Immunohistopathological analysis of brain tissues showed
WNV-specific staining only in NY99-infected HoSp (data
not shown).
Oral and cloacal virus shedding
Virus was shed both through oropharyngeal and cloacal
routes, starting from 2 dpi and lasting to 7 dpi in most
cases, although some individuals still shed virus at up to
12 dpi (Figure 4). A higher proportion of individuals in-
fected by the NY99 strain shed virus by these routes. Virus
was more abundant and more consistently detected in
oropharyngeal than in cloacal swabs, particularly between
2 and 7 dpi. At 5 dpi most cloacal and oropharyngeal
swabs were positive. The period of oropharyngeal virus
shedding for HoSp inoculated with NY99 started at 2 dpi
and ceased at 5 dpi, slightly earlier than for the HoSp inoc-
ulated with the different Euro-Mediterranean strains.
Serology
All HoSp surviving the inoculation (except the above-
mentioned bird inoculated with Italy/2008 strain, which
did not become viremic) developed antibodies to WNV
detectable by ELISA at 14 dpi (data not shown).
Discussion
The house sparrow is an abundant and widely distributed
passerine species, which shares its habitat with humans.
Although present in North America by 1850, it is in fact
native to regions of Europe, Africa and Asia [29] where
WNV circulates. HoSp are not only susceptible to WNV
infection, but are also competent hosts for WNV trans-
mission as has been shown in previous work [7,14,15].
However, most of these studies were performed with the
North American-type strain NY99 and works of this
nature using WNV strains from other continents are still
Figure 3 Viral genome load in house sparrow tissues. Viral load is plotted against each tissue analyzed by semi-quantitative real-time RT-PCR.
He = heart; Li = liver; Br = brain; Ki = kidney; Sp = spleen. Each group of eight house sparrows was sampled as described in the text. Horizontal bars
represent the mean Ct value of each tissue. Arrows indicate tissues from dead house sparrows. (*) only four spleens were sampled.
Table 3 Viral genome load in tissues from succumbing and surviving house sparrows
Organs Real-timeRT-PCR results
Succumbing HoSp Surviving HoSp (21 dpi)
NY99 Spain/2007 Italy/2009 NY99 Spain/2007 Italy/2009 Italy/2008
Heart
Positives/total 2/2 2/2 1/1 4/6 0/6 3/7 0/8
Ct (mean) 16.4 26.0 27.1 36.7 n.d. 37.8 n.d.
Ct (range) 15.7-17.1 24.6-27.5 - 35.8-37.9 - 37.5-38.3 -
Liver
Positives/total 2/2 2/2 1/1 5/6 0/6 2/7 3/8
Ct (mean) 14.2 24.5 29.6 34.5 n.d. 36.9 34.3
Ct (range) 13.5-14.8 22.9-26.2 - 31.1-37.8 - 36.4-37.4 33.0-36.1
Brain
Positives/total 2/2 2/2 1/1 3/6 0/6 3/7 3/8
Ct (mean) 18.0 31.9 27.9 32.3 n.d. 36.4 38.0
Ct (range) 17.8-18.3 31.0-32.8 - 31.3-34.2 - 35.0-39.0 36.7-39.6
Kidney Positives/total 2/2 2/2 1/1 5/6 4/6 4/7 6/8
Ct (mean) 14.6 27.9 23.6 29.0 33.1 33.1 33.3
Ct (range) 14.2-15.1 27.6-28.3 - 26.2-33.2 31.2-36.9 28.5-37.3 29.4-39.2
Spleen Positives/total 2/2 2/2 1/1 2/2 4/6 5/7 6/8
Ct (mean) 13.1 23.4 23.8 31.7 35.2 35.0 33.0
Ct (range) 13.1-13.1 22.1-24.7 - 31.6-31.7 32.7-39.1 32.3-36.8 29.7-39.6
Viral RNA was estimated by real-time RT-PCR in tissues from five different organs of either succumbing or surviving HoSp, sacrificed 21 dpi with WNV as described
in the text. Real-time RT-PCR results are expressed as positive (Ct < 40.0) over total samples analysed in each group, and as average viral genome load, expressed
as mean Ct for each tissue. The Ct ranges (maximum and minimum values) obtained in each group are also indicated. (n.d.: not detectable).
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Figure 4 Viral shedding through the a) oral and b) fecal routes.
Viral shedding was estimated by real-time RT-PCR analysis of
the oropharyngeal and cloacal swabs taken at different days
post-inoculation of WNV strains: NY99 (black bars), Spain/2007 (white
bars), Italy/2009 (diagonal striped bars) and Italy/2008 (grey bars). Error
bars represent the standard deviation of the means.
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cation and mortality rates in HoSp caused by infection
with the North American (NY99) and Kenyan (KN-3829)
strains, while the Australian (Kunjin-6453) strain was
found less pathogenic. In the present work, these results
were extended to three new WNV strains (Spain/2007,
Italy/2008 and Italy/2009) isolated in southern Europe, all
of which belong to the Western-Mediterranean cluster
within lineage 1a of WNV (see [17] for details of their
phylogenetic assignment). The methodology used closely
resembles that of the study by Langevin et al. [16] with
the exception of the differing origins of the HoSp (Spain
vs. US), a fact that could have a certain relevance due to
possible differences in the genetic background of the
birds studied. Despite this, our results confirm that HoSp
is susceptible to WNV infection: while most individuals
remain asymptomatic, a variable percentage suffers from
more severe clinical disease that can be lethal in some
instances. Thus, HoSp of European origin do not behave
differently in this regard from North American HoSp. Inaddition, our results support the main conclusion of the
study by Langevin et al. [16], that is, Old-World WNV
strains can be as pathogenic for HoSp as North American
ones. However, aside from the degree of virulence, we
observed certain differences between NY99 and the three
Euro-Mediterranean WNV strains in the course of the
infection.
Overall, compared to the Euro-Mediterranean strains,
NY99 produced greater viremia, earlier mortality, higher
morbidity, higher viral load in organs of birds either
succumbing or surviving to the infection, and earlier
and more consistent virus shedding either through oro-
pharyngeal or cloacal routes. The host-competence index
calculated for NY99 was also higher than for any of the
three Euro-Mediterranean strains examined, supporting
the hypothesis that mosquito vectors may acquire the
infection more readily when feeding from NY99-
infected HoSp than from HoSp infected with the Euro-
Mediterranean strains tested. It is remarkable that there
are so few amino-acid changes throughout the complete
polyprotein sequences (3433 amino acids) of the three
Euro-Mediterranean strains examined in this work: 16
amino-acid positions differ between Spain/2007 and both
Italian isolates, Italy/2008 and Italy/2009, while these latter
two differ mutually in only four positions. One of these
changes affects the NS3249 position. It has been shown
experimentally that, when this position is occupied by
proline (Pro) instead of threonine (Thr), the virulence
of WNV for American crows (Corvus brachyrhynchos)
is enhanced [30]. This position is occupied by Pro in
NY99, Spain/2007 and Italy/2008, and by Thr in Italy/
2009 (Table 1). Therefore, the mere presence of Pro at
NS3249 was not sufficient to determine the virulence
observed for HoSp in this study. This result is not surpris-
ing given that strains NY99 (NS3249-Pro) and KN-3829
(NS3249-Thr) behaved similarly in terms of virulence
for HoSp [16], a finding that agrees with our previous
observations [20,22].
The results shown in this work indicate that at least
some WNV strains circulating in southern Europe are
pathogenic for an avian species as common as the HoSp.
Therefore, a certain level of mortality in HoSp should also
be expected in the Euro-Mediterranean region in areas
affected by WNV outbreaks. Remarkably, no substantial
wild bird mortalities have ever been observed in associ-
ation with WNV circulation in this region, a circumstance
that contrasts with the situation in North America, where
wild bird mortalities (affecting HoSp among other species)
are widespread [31]. Moreover, wild-bird mortality events
in North America are considered as an early-warning
signal for monitoring WNV circulation in the field. This
type of alert based on wild-bird mortality is seldom of any
– or no – use in Europe and the Mediterranean, which
emphasizes that, despite dealing with the same pathogen,
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of each transmission scenario.
The difference between North America and the Euro-
Mediterranean region in observed wild bird mortality
due to WNV still demands a satisfactory explanation.
Possible reasons including either the greater virulence of
North American WNV strains or a higher susceptibility
of North American bird species have been proposed.
However, the results obtained in this work do not match
particularly well either of these hypotheses: on the one
hand, HoSp from both continents are susceptible to lethal
WNV infection but, on the other, some WNV strains in
Europe are not so different from the North American type
strain (NY99) in terms of mortality for HoSp. Therefore,
other hypotheses must be formulated and experimentally
tested to explain these facts. In this regard, NY99 exhib-
ited a higher replication capacity in HoSp than the Euro-
Mediterranean WNV strains analysed. Accordingly, NY99
also had greater viremia profiles, greater virus shedding,
an earlier onset of clinical signs and greater morbidity
in two clinically affected individuals – neither of which
recovered within the monitoring period – that under
natural conditions (i.e. in the field) would have been
unlikely to survive. Although this higher replication
capacity did not result in a significant increase in mor-
tality, it did give rise to higher mean peak viremias,
which in turn can influence the host competence index.
This index was also found to be higher for NY99 than
for the other WNV strains tested. This fact reveals an
enhanced amplification capacity that would hypothetic-
ally lead to more transmission events in cases of HoSp
infection with NY99-like strains, eventually giving rise
to a more exacerbated cycle, a greater basic reproductive
ratio (R0), and consequently, more infections and thus
more deaths. The higher viral loads observed in organs
also suggest a higher potential for viremia recrudescence
and long-lasting infections for NY99, thus transmission by
predation would also be more likely.
The NY99, Spain/2007 and Italy/2009 strains were
isolated from diseased birds in the context of WNV
outbreaks (that is, accompanied by similar birds showing
evidence of WNV infection that also succumbed to it),
whereas the Italy/2008 strain was isolated from a magpie
that was shot during a pest-control programme. Inter-
estingly, Italy/2008 did not cause any mortality in the
infected HoSp. This fact could be indicative of the poten-
tial circulation in Europe of low-pathogenicity WNV
strains that could be more difficult to detect and isolate
given that they are not associated with bird mortalities
[32]. However, this result should not be over-interpreted
since 1) the observed differences in mortality in HoSp
inoculated with the different WNV strains derive from
a small number of inoculated birds; 2) a given WNV
strain can be highly virulent in a given host species butbe of low virulence in other(s), and 3) the fact that the
magpie from which Italy/2008 was isolated was shot
does not strictly mean that it was not affected by the
disease. Further work is necessary to determine whether
or not these strains are different in terms of their virulence
for a wider range of hosts.
Conclusion
The house sparrow is a suitable model for studying West
Nile virus infection. This study confirms that it is suscep-
tible to WNV infection and disease, and is a competent
host for the transmission of WNV strains from both North
America and the Euro-Mediterranean region. Although
the differences observed in wild bird mortality between
the continents remain unexplained, variations in host
competence among WNV strains circulating in each
continent could play a role. Further studies are needed
to clarify this finding and, in particular, more experi-
mental infections using a wider range of WNV strains
and host species from the two continents should be
performed to allow for more thorough comparisons.
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